jp morgan glp-1 Unpacking the Hype JPM 2026] D&D Pharmatech chose

These medications can be incredibly effective at helping patients lose significant amounts of weight, often very quickly

GLP-1 agonists (glucagon-like peptide-1 receptor agonists) work by mimicking a hormone your body naturally produces to manage blood sugar and digestion

Due to their preclinical testing and lack of comparison with other dual receptor agonists such as tirzepatide, further studies are needed to determine whether the effects of these unimolecular compounds are superior to those of clinically tested drugs

While mild reactions might only require antihistamines and medical consultation, severe symptoms demand immediate emergency attention

Durability: Weight often returns after stopping treatment, especially without lifestyle and coaching support

GLP-1 medications bind to and activate the GLP-1 receptor in the brain, pancreas, gut, heart, liver, kidneys and blood vessels, triggering a wide range of beneficial metabolic effects. Meanwhile, tirzepatide is a dual GIP/GLP-1 receptor agonist that targets both GIP and GLP-1 receptors